Ebola transmission by aerosols confirmed.

Ok - That's a really spooky bit of mindf**k to think about.

How about sweaty hands? Plenty of those in Africa.

Damn people this will rage thru North America like small pox wiped out the natives or the Spanish flu.We don't have any natural immune defense against this,many people in Africa have survived outbreaks in their villages.And I shutter at the thought of all those border babies being inoculated at those centers,With in weeks those BBS will be attending school with our kids.Terrifying really;the perfect storm

Meanwhile day after day you can still catch an international flight straight from the heart of the Ebola zone -- Conakry Guinea -- direct to Paris France

[link to www.airportia.com]

Last Edited by goodmockingbird on 08/02/2014 01:49 AM

All of the numbers released by the WHO since the start of this are in the links on this page. The last figures given are for the period July 24 to July 27.

[link to www.afro.who.int]

Our Walmart has hand sanitizor at the registers

Not good at all.

An infected person sneezes into their hands and then touches.....Door handles, shopping carts, gas pump handles.....where will it end?

Last Edited by Morpheus on 08/02/2014 04:14 AM

I did too!

Yes....and I'll bet they wanted illegals blamed for it to cover their tracks. They'll be spraying it everywhere...evil monsters.

Amazon, of course....
[link to www.amazon.com]

Good excuse for instant cashless systems to be implemented, no? (never let a good crisis go to waste and all)

it is all theatre.
fear away if you must. there is nothing to fear.
ebol-a my hole-a!

RFID will be your/our salvation/cure.

So, it can be spread via "chemtrails"? I always thought about how easy it would be to spray the entire country at once...People are so used to seeing the chemtrails all over, they'd never suspect a thing.

Well, what do ya know! There are "some" who would Genetically immune to ebola and Marburg due to a mutation of the NPC1 protein. They are grouped in Ashkenazi Jews and Nova Scotians of Yarmouth county.




"The researchers looked for proteins that Ebola virus might exploit to enter the cell’s cytoplasm. The protein Niemann-Pick C1 (NPC1) stood out to the team.

“We found that if your cells don’t make this protein, they cannot be infected by Ebola virus,” Kartik Chandran, assistant professor of microbiology & immunology at Einstein, said in a press release.
[link to www.redorbit.com]


"Functionality of NPC1 is required for infection by authentic Ebola and Marburg viruses."

[link to www.nature.com]

"Approximately 95% of Niemann–Pick type C cases are caused by genetic mutations in the NPC1 gene"(Mellon SH, Gong W, Schonemann MD; March 2008)

"The incidence among Ashkenazi Jews is estimated to be approximately 1 in 40,000 for type A of Niemann–Pick disease.[3] The incidence of both Niemann–Pick disease types A and B in all other populations is estimated to be 1 in 250,000.[3] The incidence of Niemann–Pick disease type C is estimated to be 1 in 150,000"

Type D Niemann–Pick has only been found in the French Canadian population of Yarmouth County, Nova Scotia, and is now known to be allelic with Niemann–Pick type C.
[link to en.m.wikipedia.org]

Last Edited by LePALMA on 08/03/2014 09:45 AM

MODE OF TRANSMISSION: In an outbreak, it is hypothesized that the first patient becomes infected as a result of contact with an infected animal (15). Person-to-person transmission occurs via close personal contact with an infected individual or their body fluids during the late stages of infection or after death (1, 2, 15, 27). Nosocomial infections can occur through contact with infected body fluids due to the reuse of unsterilized syringes, needles, or other medical equipment contaminated with these fluids (1, 2). Humans may be infected by handling sick or dead non-human primates and are also at risk when handling the bodies of deceased humans in preparation for funerals, suggesting possible transmission through aerosol droplets (2, 6, 28). In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated (1, 6, 13). The importance of this route of transmission is not clear. Poor hygienic conditions can aid the spread of the virus (6).

[link to www.phac-aspc.gc.ca]

Filoviruses like Ebola have been of interest to the Pentagon since the late 1970s, mainly because Ebola and its fellow viruses have high mortality rates — in the current outbreak, roughly 60 percent to 72 percent of those who have contracted the disease have died — and its stable nature in aerosol make it attractive as a potential biological weapon.

[link to www.militarytimes.com]

This is what I read from a canadian journal on the virus. SURVIVAL OUTSIDE HOST: The virus can survive in liquid or dried material for a number of days (23). Infectivity is found to be stable at room temperature or at 4°C for several days, and indefinitely stable at -70°C (6, 20). Infectivity can be preserved by lyophilisation.

[link to youtu.be]

Russian Health Official: The current epidemic of Ebola may be due to the use of biological weapons
Thread: Russian Health Official: The current epidemic of Ebola may be due to the use of biological weapons

In theory, no. The genetic material isn't similar enough for recombination. In a lab? Maybe...if it hasn't already been done.

Easy to understand article with explanation:
[link to genetics.thetech.org]

Full on, now.

They didn't invent the virus. It was discovered in Bundibugyo, Uganda during a outbreak from Nov through Jan.
They isolated the bug and discovered it was at least 40% different from Ivory Coast Ebola, so they claimed the bug, deposited it in the CDC and named it.
Now they use the information to develop vaccines, at least according to the patent

There was a gene sequence section that I couldn't follow, but other than that it's pretty easy to read.

From the patent:
The invention provides the isolated human Ebola (hEbola) viruses denoted as Bundibugyo (EboBun) deposited with the Centers for Disease Control and Prevention (“CDC”; Atlanta, Ga., United States of America) on Nov. 26, 2007 and accorded an accession number 200706291. This deposit was
[link to patents.google.com (secure)]

Weaponized.

CDC - Centers for Disease Creation